dammarenediol

07/01/2021 - "Retraction of "Dammarenediol suppresses the growth, migration and invasion of human osteosarcoma cells by modulating PI3K/Akt and STAT-3 signaling pathways", by Yingbin Wu, Yue Chen, Zheng Xu, Ming Xiang. "
07/01/2021 - "Retraction Note to: Dammarenediol suppresses the growth, migration and invasion of human osteosarcoma cells by modulating PI3K/Akt and STAT-3 signaling pathways."
09/01/2020 - "The osteosarcoma cell growth was inhibited by dammarenediol in a dose-dependent manner, while the normal bone cell line was not affected much. "
09/01/2020 - "The present work was aimed at exploring the anticancer potential of dammarenediol against human osteosarcoma cells together with exploration of its mechanism of action. "
09/01/2020 - "Dammarenediol suppresses the growth, migration and invasion of human osteosarcoma cells by modulating PI3K/Akt and STAT-3 signaling pathways."

01/01/2023 - "In agreement with these results, the contents of dammarenediol-type ginsenosides were higher in the tetraploid species relative to the diploid species. "

09/01/2020 - "Dammarenediol further declined the viability of cancer cells along with restricting their metastatic potential. "

09/01/2020 - "Dammarenediol effectively restricted the growth and metastasis of osteosarcoma cells in vitro by inhibiting the PI3K/Akt and STAT-3 signaling pathways."

12/01/2015 - "Our results suggest that the natural drug dammarenediol-II may have the ability to prevent diabetic microvascular complications, including diabetic retinopathy."